Why Adc Therapeutics SA (NYSE:ADCT) Stock Slipped -12.07% in Last Month?

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

The growth of Adc Therapeutics SA (ADCT) Stock is expected to continue

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

Is it possible to sustain this rally? Adc Therapeutics SA (ADCT) Stock

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

The performance of Adc Therapeutics SA (ADCT) Stock has improved

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

What makes Adc Therapeutics SA (ADCT) Stock unique?

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

There Is Nothing Like Adc Therapeutics SA (ADCT) Stock

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

The latest Adc Therapeutics SA (ADCT) Stock Technical Bulletin

Cantor Fitzgerald raised the price target for the Adc Therapeutics SA (NYSE:ADCT) stock to “an Overweight”. The rating was released on May 30, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on April 24, 2023, from Neutral to Underperform and set the price objective to $2. […]

Unlock Your Investment Potential: Get Your 100% Free eBook

Best Space Stocks To Buy

A detailed analysis of Three Best Space Stocks to Buy, each selected based on Innovations, Growth Metrics & Achievements

No thanks

Best Space Stocks to Buy!

Unlock Your Investment Potential: Get Your 100% Free eBook

A Detail Analysis of Three Best Space Stocks to Buy, Eash Selected Based on Innovations, Growth Metrics & Achievements